Half Yearly Compliance Certificate Under Regulation 7(3) Of SEBI Listing Regulations, 2015
In compliance to Regulation 7(3) of SEBI Listing Regulations, 2015; we furnish hereunder the Certificate, duly signed by the Compliance Officer of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company') and by the Authorized Representative of 'Purva Sharegistry (India) Pvt. Ltd.', designated Share Transfer Agent of the Company for the half year ended September 30, 2018. Shareholding for the Period Ended September 30, 2018
Fredun Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Daulat MedhoraDesignation :- Director Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Fredun Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Shareholder Meeting / Postal Ballot-Outcome of AGM
In compliance to Regulation 44(3) of SEBI Listing Regulations, 2015; we hereby submit the Voting Results of the of the business transacted at the 31st Annual General Meeting (the 'AGM') of the Company held on Thursday, September 27, 2018. Proceeding Of 31St Annual General Meeting
In compliance to Regulation 30 read with Schedule III of SEBI Listing Regulations, 2015; we are pleased to submit the Proceedings of the 31st Annual General Meeting of the Company. Declaration Under Regulation 31 Of The SEBI SAST Regulations
Revised - Announcement Under Regulation 31 Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations, 2011. Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has now received the revised disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Daulat Medhora Declaration Under Regulation 31 Of The SEBI SAST Regulations
Announcement Under Regulation 31 Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations, 2011. Fixes Book Closure for Final Dividend & AGM (Cut-off date for e-voting)
Fredun Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 21, 2018 to September 27, 2018 (both days inclusive) for the purpose of Payment of Final Dividend & 31st Annual General Meeting (AGM) of the Company to be held on September 27, 2018.